Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.900
+0.080 (2.09%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Cytek Biosciences Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$6.00
Upside
+53.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +79.49% | May 28, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3.5 → $3 | Strong Sell | Maintains | $3.5 → $3 | -23.08% | May 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +53.85% | Mar 19, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +105.13% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $5.25 → $4.5 | Strong Sell | Maintains | $5.25 → $4.5 | +15.38% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4.5 → $5.25 | Strong Sell | Maintains | $4.5 → $5.25 | +34.62% | Feb 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Strong Sell Downgrades $7 → $4.5 | Strong Buy → Strong Sell | Downgrades | $7 → $4.5 | +15.38% | Jan 31, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $8.5 | Buy | Maintains | $8 → $8.5 | +117.95% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +105.13% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +79.49% | Aug 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8.5 | Buy | Maintains | $10 → $8.5 | +117.95% | May 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +105.13% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +156.41% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +156.41% | Feb 29, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $9 | Buy | Initiates | $9 | +130.77% | Dec 14, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +79.49% | Nov 9, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.